Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hersh

Showing results (51-60 of 572) with videos related to

Pageof 58
Sort By:
World Neurosurgery|January 29, 2022
Management of Glioblastoma Metastatic to the Vertebral SpineAndrew M Hersh, Daniel Lubelski, Nicholas Theodore
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Studies of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity among patients with acute leukemia in complete remissionM Talpaz, M Bielski, E M Hersh
Cancer Immunology, Immunotherapy : CII|August 16, 2003
Naturally occurring B-cell responses to breast cancerJulia A Coronella-Wood, Evan M Hersh
Nursing Times|May 22, 1991
Ditiocarb useful in HIV therapyE M Hersh, G Brewton, D Abrams
Cancer Research|June 1, 1981
Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2L Milas, E M Hersh, N Hunter
Current Opinion in Neurology|March 27, 2024
Understanding multiple sclerosis as a disease spectrum: above and below the clinical thresholdStephen Krieger, Karin Cook, Carrie M Hersh
International Journal of Molecular Sciences|April 23, 2022
Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-OncologyAndrew M Hersh, Safwan Alomari, Betty M Tyler
Transplantation|May 1, 1970
Human immune response to a xenogeneic nucleated cellJ E Harris, E M Hersh, S Huggins
Clinical and Experimental Immunology|August 1, 1970
L-asparaginase: suppression of the immune response of mice to sheep red blood cellsR Ohno, J E Harris, E M Hersh
Multiple Sclerosis and Related Disorders|April 11, 2021
How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider surveyElizabeth H Morrison, Katelyn Michtich, Carrie M Hersh
Pageof 58

Showing results (51-60 of 572) with videos related to

Sort By:
Pageof 58
World Neurosurgery|January 29, 2022
Management of Glioblastoma Metastatic to the Vertebral SpineAndrew M Hersh, Daniel Lubelski, Nicholas Theodore
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Studies of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity among patients with acute leukemia in complete remissionM Talpaz, M Bielski, E M Hersh
Cancer Immunology, Immunotherapy : CII|August 16, 2003
Naturally occurring B-cell responses to breast cancerJulia A Coronella-Wood, Evan M Hersh
Nursing Times|May 22, 1991
Ditiocarb useful in HIV therapyE M Hersh, G Brewton, D Abrams
Cancer Research|June 1, 1981
Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2L Milas, E M Hersh, N Hunter
Current Opinion in Neurology|March 27, 2024
Understanding multiple sclerosis as a disease spectrum: above and below the clinical thresholdStephen Krieger, Karin Cook, Carrie M Hersh
International Journal of Molecular Sciences|April 23, 2022
Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-OncologyAndrew M Hersh, Safwan Alomari, Betty M Tyler
Transplantation|May 1, 1970
Human immune response to a xenogeneic nucleated cellJ E Harris, E M Hersh, S Huggins
Clinical and Experimental Immunology|August 1, 1970
L-asparaginase: suppression of the immune response of mice to sheep red blood cellsR Ohno, J E Harris, E M Hersh
Multiple Sclerosis and Related Disorders|April 11, 2021
How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider surveyElizabeth H Morrison, Katelyn Michtich, Carrie M Hersh
Pageof 58